Population Pharmacokinetics and Exposure-Response Analyses for Risankizumab in Patients with Active Psoriatic Arthritis.
Neha ThakreRonilda R D'CunhaAline GoebelWei LiuYinuo PangAhmed A SuleimanPublished in: Rheumatology and therapy (2022)
NCT02596217, NCT02719171, NCT02986373, NCT03671148, and NCT03675308.
Keyphrases